Emina Torlakovic
University of Saskatchewan
H-index: 47
North America-Canada
Top articles of Emina Torlakovic
A Case Report of Gelatinous Transformation of Bone Marrow Following Lymphoma and a Novel, Potential Treatment
2023/9/14
Logan Hahn
H-Index: 1
Emina Torlakovic
H-Index: 23
Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways
Frontiers in Genetics
2024/2/2
A Consortium for Analytic Standardization in Immunohistochemistry
2023/5/1
CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing
The Journal of Molecular Diagnostics
2023/3/1
In Reply: Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry Calibration
Modern Pathology
2023/2/1
Reinventing Nuclear Histo-score Utilizing Inherent Morphologic Cutoffs: Blue-brown Color H-score (BBC-HS)
Applied Immunohistochemistry & Molecular Morphology
2023/8/1
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus
Archives of Pathology & Laboratory Medicine
2023/1/1
Ahmet Dogan
H-Index: 13
Kai Fu
H-Index: 18
Deniz Peker
H-Index: 8
Mina L Xu
H-Index: 14
Emina Torlakovic
H-Index: 23
PD-L1 IHC testing: issues with interchangeability evidence based on laboratory-developed assays of unknown analytical performance
Gastric Cancer
2022/11
Dual Expression of Immunoglobulin Light Chains in Plasma Cell Myeloma: A Case Report and Literature Review
Applied Immunohistochemistry & Molecular Morphology
2022/10/27
Simultaneous imaging and therapy using epitope-specific anti-epidermal growth factor receptor (EGFR) antibody conjugates
Pharmaceutics
2022/9/10
Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934
Modern Pathology
2022/3
Proficiency testing to improve interobserver agreement for mismatch repair deficiency immunohistochemistry: An invitation to join CBQA readout
2022/2/1
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer
Lung Cancer
2021/10/1
Prevalence and heterogeneity of PD-L1 expression by 22C3 assay in routine population-based and reflexive clinical testing in lung cancer
Journal of Thoracic Oncology
2021/9/1
Jessica Weiss
H-Index: 5
Michael Cabanero
H-Index: 12
Prodipto Pal
H-Index: 11
Emina Torlakovic
H-Index: 23
Human, mouse, and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment
Experimental Hematology
2021/8/1
Dita Gratzinger
H-Index: 19
Emina Torlakovic
H-Index: 23
Abstract LB034: Analysis of PD-L1 IHC tests using NIST SRM 1934-traceable reference materials: A new paradigm for development of predictive IHC biomarkers
Cancer Research
2021/7/1
Development and validation of measurement traceability for in situ immunoassays
Clinical Chemistry
2021/5/1
Abstract PS5-46: Introduction and clinical validation of metrology standards for immunohistochemistry (IHC); New tool for standardization of estrogen receptor (ER) IHC assay in …
Cancer Research
2021/2/15
Canadian consensus for biomarker testing and treatment of TRK fusion cancer in adults
Current Oncology
2021/1/9
A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution
Diagnostic Pathology
2021/12
